Balanced news tone
News Sentiment
DCGO sentiment intelligence
DocGo Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+7.5% over one week, +3.0% over four weeks, trend inactive, and below fair value.
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of DocGo Inc. (DCGO) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential legal rights and options, including
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 08 Jul 2026 15:40
- Source
- TradingView
DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026
DocGo (NASDAQ: DCGO) has extended its existing $26 million share repurchase program from June 30, 2026, to December 31, 2026. This allows the company more time to buy back up to $26 million of its common stock through various methods, including open market transactions and Rule 1
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 Jul 2026 20:39
- Source
- Stock Titan
DocGo extends $26M share repurchase program expiration to Dec. 31, 2026
DocGo (DCGO) has announced an extension of its $26 million share repurchase program. The expiration date for the program has been moved from June 30, 2026, to December 31, 2026, with no other changes made. The program allows for common stock purchases through various methods and
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 Jul 2026 20:39
- Source
- TradingView
Enterprise value to EBITDA forward of DocGo Inc. – NASDAQ:DCGO
This page provides financial data for DocGo Inc. (NASDAQ: DCGO), specifically focusing on its enterprise value to EBITDA forward metric. It appears to be a financial data snippet from TradingView, offering a quick overview of this specific financial ratio for the company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 12:39
- Source
- TradingView
Price to book forward of DocGo Inc. – NASDAQ:DCGO
This article displays the "Price to book forward" value for DocGo Inc. (NASDAQ: DCGO). It is presented within the context of financial data available on TradingView for the healthcare services company. The specific numerical value for the metric is awaited.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 08:40
- Source
- TradingView
Price to sales forward of DocGo Inc. – NASDAQ:DCGO
The article provides a table showing the "Price to sales forward" for DocGo Inc. (NASDAQ: DCGO). It lists the period, value, change, and percentage change for this financial metric. The content highlights that the data for DocGo Inc. is available on TradingView, within the Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 21:12
- Source
- TradingView
Price to earnings forward of DocGo Inc. – NASDAQ:DCGO
The article provides a financial overview of DocGo Inc. (NASDAQ:DCGO), specifically mentioning its price to earnings forward metric. It indicates that no trades have occurred for the stock on the Nasdaq Stock Market as of market close. The content is primarily a data page from Tr
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 18:10
- Source
- TradingView
DocGo Inc (DCGO) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for DocGo Inc (DCGO), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 45th out of 76 in its industry, with analysts generally recommending a "Buy" trend. The
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jun 2026 06:10
- Source
- TradingKey
DocGo shareholders approve reverse stock split and board nominees at annual meeting
DocGo Inc. shareholders approved a reverse stock split, the election of two Class II directors, Vina Leite and James M. Travers, and executive compensation at their 2026 Annual Meeting. They also ratified the appointment of Urish Popeck & Co., LLC as the independent auditor. Two
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 05:41
- Source
- Investing.com Nigeria
DocGo Inc (DCGO) Institutional Confidence
DocGo Inc (DCGO) has an institutional shareholding score of 3.00, placing it 56th out of 76 in the Healthcare Providers & Services industry. The current institutional shareholding proportion is 43.34%, which reflects a 45.16% decrease quarter-over-quarter. James Simons is the lar
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 19 Jun 2026 05:41
- Source
- TradingKey
DocGo (NASDAQ: DCGO) holders OK reverse split and reject officer exculpation
DocGo (NASDAQ: DCGO) stockholders approved a reverse stock split authorization, director elections, and executive compensation on an advisory basis at their 2026 annual meeting. However, they rejected proposed charter amendments related to corporate opportunities and officer liab
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 21:11
- Source
- Stock Titan
DocGo Inc (DCGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for DocGo Inc (DCGO), detailing its financial performance by region. For the reported period, the United States accounted for 83.26% of revenue with $268.25 million, while the United Kingdom contributed 16.74% with $53.94 million. The com
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 17:40
- Source
- TradingKey
DocGo Inc (DCGO) Valuation: PE, PB & Fair Value Analysis
DocGo Inc (DCGO) currently has a valuation score of 8.47, placing it 43rd out of 76 in the Healthcare Providers & Services industry. Its P/E ratio is -0.30, significantly below its recent high and above its recent low. Key valuation metrics such as P/B, P/S, and P/CF have not yet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 10:10
- Source
- TradingKey
DocGo Inc (DCGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of DocGo Inc (DCGO), detailing its price momentum score, current trading range between support and resistance levels, and indicator readings. It shows that DocGo Inc's current price momentum score is 4.44, ranking 71 out of 76 in its ind
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 18 Jun 2026 10:10
- Source
- TradingKey
DocGo Inc (DCGO) Financial Health: Profitability & Balance Sheet Analysis
DocGo Inc (DCGO) currently has a financial score of 7.20, placing it 52nd out of 76 in the Healthcare Providers & Services industry, indicating stable financial status and high operating efficiency. The company reported a quarterly revenue of $75.55M, marking a 21.33% year-over-y
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 18 Jun 2026 09:10
- Source
- TradingKey
DCGO: Transitioning to proactive, tech-enabled care, the company targets growth and profitability
DocGo (DCGO) is shifting its business model from emergency response to a technology-driven, proactive healthcare delivery system. This new strategy, which includes in-home, virtual, and transportation services and integrates SteadyMD and the Care Anywhere platform, is aimed at im
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 11 Jun 2026 08:09
- Source
- TradingView
DocGo (DCGO) Goldman Sachs 47th Annual Global Healthcare Conference 2026 Summary
DocGo (DCGO) presented at the Goldman Sachs 47th Annual Global Healthcare Conference in 2026, highlighting its transition from emergency response to proactive care and transportation. The company detailed its integrated technology platform, which aids in efficient medical transpo
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 08 Jun 2026 06:40
- Source
- Quartr
DocGo Launches Mobile Phlebotomy Services in South Florida
DocGo has introduced new mobile phlebotomy services in South Florida, allowing patients to get blood draws and specimen collection at their homes or workplaces. This expansion aims to enhance access to diagnostic testing by deploying trained phlebotomists who then transport sampl
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 04 Jun 2026 11:39
- Source
- www.geneonline.com
DocGo launches mobile phlebotomy services in southern Florida By Investing.com
DocGo Inc.'s PTI Health subsidiary has launched mobile phlebotomy services in southern Florida, expanding its relationship with a major national clinical laboratory. This expansion allows PTI Health to provide blood collection and at-home testing services, operating with a low ca
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 04 Jun 2026 06:09
- Source
- Investing.com India
DocGo launches mobile phlebotomy services in southern Florida
DocGo Inc.'s PTI Health subsidiary has expanded its services by launching mobile phlebotomy in southern Florida, partnering with a major national clinical laboratory. This expansion, operating on a low capital investment model, aims to provide blood collection and at-home testing
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 03 Jun 2026 12:09
- Source
- Investing.com UK
At-home blood draws come to South Florida as DocGo expands
DocGo (Nasdaq: DCGO) has launched mobile phlebotomy services in South Florida through its subsidiary PTI Health by DocGo. This expansion includes an extended partnership with a major national clinical laboratory to provide services across the Southeast, leveraging Florida's signi
- Tone
- Positive 73/100
- Event
- Deals and strategy
- Published
- 03 Jun 2026 11:39
- Source
- Stock Titan
DCGO - DocGo Inc Stock Price and Quote
This article provides a comprehensive overview of DocGo Inc. (DCGO) stock, including its current price, financial metrics, analyst ratings, and recent news. It details the company's market performance, key financial figures, and a history of news announcements and analyst actions
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 30 May 2026 22:39
- Source
- Finviz
DocGo targets profitability as it pivots to mobile health, medical transport
The provided article content is empty. Therefore, a summary cannot be generated.
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 28 May 2026 06:09
- Source
- MSN
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
DocGo (Nasdaq: DCGO) announced that CEO Lee Bienstock will participate in a fireside chat and hold 1x1 meetings at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8th. A webcast of the event will be available on DocGo's investor relations website. DocGo is a le
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 26 May 2026 11:09
- Source
- Business Wire
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth
DocGo (DCGO) presented its 2026 revenue guidance, projecting between $310 million and $315 million. The company aims for significant growth in its mobile phlebotomy services, targeting a 75% increase by 2026, alongside expanding its medical transportation segment. DocGo also anti
- Tone
- Positive 71/100
- Event
- Guidance
- Published
- 19 May 2026 04:38
- Source
- MSN
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets
DocGo's (DCGO) modeled fair value has been revised down from US$2.10 to US$1.87, reflecting a mixed outlook from analysts. While optimism surrounds its transport business, concerns about execution persist, leading to lower price targets like Stifel's US$2.50. The company recently
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 16 May 2026 18:10
- Source
- Market source
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
DocGo Inc (DCGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 May 2026 07:08
- Source
- GuruFocus.com
Needham reiterates DocGo stock rating on SteadyMD strength
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 12 May 2026 07:00
- Source
- Investing.com
DocGo Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 23:05
- Source
- MarketBeat